| Period Ending | 31-Mar-2010 | 31-Mar-2009 | 31-Mar-2008 | 31-Mar-2007 |
|---|
|
Total Revenue
|
343,088,000
|
331,511,000
|
312,684,000
|
214,107,000
| | Cost of Revenue | 6,686,000 | 6,832,000 | 6,288,000 | 4,494,000 | | |
Gross Profit
|
336,403,000
|
324,679,000
|
306,396,000
|
209,613,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 277,332,000 | 281,858,000 | 270,464,000 | 180,162,000 | | | |
Operating Income or Loss
|
65,756,000
|
49,653,000
|
42,219,000
|
33,945,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes |
-
|
-
|
-
|
-
|
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 17,322,000 | 15,859,000 | 11,067,000 | 7,611,000 |
|
Minority Interest | (1,731,000) | 1,975,000 | 2,830,000 | 1,272,000 |
|
|
|
Net Income From Continuing Ops | 46,703,000 | 35,770,000 | 33,982,000 | 27,606,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
46,703,000
|
35,770,000
|
33,982,000
|
27,606,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|